107 related articles for article (PubMed ID: 20446263)
21. Complement component C6 deficiency in a Spanish family: implications for clinical and molecular diagnosis.
Moya-Quiles MR; Bernardo-Pisa MV; Martínez P; Gimeno L; Bosch A; Salgado G; Martínez-Banaclocha H; Eguia J; Campillo JA; Muro M; Vidal-Bugallo JB; Alvarez-López MR; García-Alonso AM
Gene; 2013 May; 521(1):204-6. PubMed ID: 23537992
[TBL] [Abstract][Full Text] [Related]
22. Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, sub-Saharan Africa: implications for the susceptibility to meningococcal disease.
Franco-Jarava C; Comas D; Orren A; Hernández-González M; Colobran R
Clin Exp Immunol; 2017 Aug; 189(2):226-231. PubMed ID: 28369827
[TBL] [Abstract][Full Text] [Related]
23. Meningococcal meningitis in familial deficiency of the fifth component of complement.
Peter G; Weigert MB; Bissel AR; Gold R; Kreutzer D; McLean RH
Pediatrics; 1981 Jun; 67(6):882-6. PubMed ID: 6785713
[TBL] [Abstract][Full Text] [Related]
24. Complement-induced ultrastructural membrane lesions: requirement for terminal components.
Packman CH; Rosenfeld SI; Weed RI; Leddy JP
J Immunol; 1976 Nov; 117(5 Pt.2):1883-9. PubMed ID: 993584
[TBL] [Abstract][Full Text] [Related]
25. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
Hetland G; Bungum L
APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of three new mutations causing C5 deficiency in two non-related families.
López-Lera A; Garrido S; de la Cruz RM; Fontán G; López-Trascasa M
Mol Immunol; 2009 Jul; 46(11-12):2340-7. PubMed ID: 19414197
[TBL] [Abstract][Full Text] [Related]
27. [Hereditary complement deficiency in Tunisian adults with purulent meningitis].
Abdelmalek R; Kallel Sallemi M; Zerzri Y; Kilani B; Laadhar L; Kanoun F; Tiouiri Benaissa H; Ghoubantini A; Ammari L; Makni S; Ben Chaabane T
Med Mal Infect; 2011 Apr; 41(4):206-8. PubMed ID: 21195566
[TBL] [Abstract][Full Text] [Related]
28. Complement deficiency syndromes and bacterial infections.
Veitch J; Love C; Chaudhuri AK; Whaley K
Prog Brain Res; 1983; 59():69-80. PubMed ID: 6665131
[No Abstract] [Full Text] [Related]
29. [A case of C5 deficiency with polyarthritis].
Mimori M; Yamauchi I; Nishimura Y; Takada K; Inai S
Rinsho Byori; 1992 Jun; 40(6):660-4. PubMed ID: 1513039
[TBL] [Abstract][Full Text] [Related]
30. [Complement deficiencies and meningococcal disease in The Netherlands].
Swart AG; Fijen CA; te Bulte MT; Daha MR; Dankert J; Kuijper EJ
Ned Tijdschr Geneeskd; 1993 Jun; 137(23):1147-52. PubMed ID: 8316311
[TBL] [Abstract][Full Text] [Related]
31. The role of complement in anti-bacterial defence.
D'Amelio R; Biselli R
Ann Ital Med Int; 1994; 9(3):173-7. PubMed ID: 7946895
[TBL] [Abstract][Full Text] [Related]
32. Hereditary complement deficiency in survivors of meningococcal disease: high prevalence of C7/C8 deficiency in Sephardic (Moroccan) Jews.
Zimran A; Rudensky B; Kramer MR; Tedesco F; Ehrenfeld M; Raz R; Greif Z; Gelber M; Lishner M; Golan E
Q J Med; 1987 Apr; 63(240):349-58. PubMed ID: 3685247
[TBL] [Abstract][Full Text] [Related]
33. [Combined-heterozygous deficiency of complement C7 in a patient with recurrent meningitis].
Schirinzi R; Lantin JP; Frémeaux-Bacchi V; Schifferli JA; Trendelenburg M
Med Klin (Munich); 2006 Aug; 101(8):655-8. PubMed ID: 16896572
[TBL] [Abstract][Full Text] [Related]
34. Complement component C5 and C6 mutation screening indicated in meningococcal disease in South Africa.
Owen EP; Leisegang F; Whitelaw A; Simpson J; Baker S; Würzner R; Potter P; Orren A
S Afr Med J; 2012 May; 102(6):525-7. PubMed ID: 22668955
[TBL] [Abstract][Full Text] [Related]
35. The complement profile in relation to the "reactor" state: a study in the immediate post-partum period.
Mak LW
Clin Exp Immunol; 1978 Mar; 31(3):419-25. PubMed ID: 657587
[TBL] [Abstract][Full Text] [Related]
36. Serum complement profile in human leprosy and its comparison with immune complex diseases.
Saha K; Chakraborty AK
Int J Lepr Other Mycobact Dis; 1977; 45(4):327-37. PubMed ID: 147246
[TBL] [Abstract][Full Text] [Related]
37. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor.
Wyatt RJ; Bridges RB; Halatek DG
J Clin Lab Immunol; 1981 Sep; 6(2):131-5. PubMed ID: 7288869
[TBL] [Abstract][Full Text] [Related]
38. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
Hammer CH; Hänsch G; Gresham HD; Shin ML
J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
40. Terminal complement components play a role in the expression of C5a.
Gresham HD; Renfer L; Hammer CH; Frank MM
J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]